Ascentage Pharma (6855 HK)

Analysis

Health Care • China

Ascentage Pharma is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel small-molecule therapies for cancers, hepatitis B virus, and certain age-related diseases. The company specializes in therapies that inhibit protein-protein interactions to restore programmed cell death, with lead assets including olverembatinib and lisaftoclax for hematological malignancies. Ascentage Pharma was founded in 2009 and is headquartered in Suzhou, China.

Refresh

Company Event • 25 Mar 2027 20:00 • Upcoming

Add To Calendar

H2 2026

Company Event • 20 Aug 2026 20:00 • Latest

H1 2026

Company Event • 03 Jun 2026 20:10

Jefferies Global Healthcare Conference 2026

Company Event • 26 Mar 2026 20:00

H2 2025

Company Event • 14 Jan 2026 17:00 • Upcoming